WDR5 and cancer: At first blush, it makes sense that if inhibiting the WIN site of WDR5 offers therapeutic benefit in some malignant settings, then clearing the entirety of WDR5 and its “oncogenic” functions [37] from a cancer cell should amplify and extend those benefits.